Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Draft Bill Aims To Clarify FDA Regulation Of Mobile Medical Apps

This article was originally published in The Gray Sheet

Executive Summary

Draft legislation obtained by “The Gray Sheet” that seeks to restrain FDA’s oversight of mobile apps is being circulated for stakeholder comment by Rep. Marsha Blackburn, R-Tenn., and colleagues.

Advertisement

Related Content

US Midterms: Industry Loses Some Supporters In Congress, But Retains Many
Voters Likely To Pick And Choose Among Device Industry Favorites In Close Races
'Cures' Bill Circumvents FDA On Medical Software Regs
Bipartisan House Bill Introduced To Curb FDA Health IT Oversight
Bipartisan House Bill Introduced To Curb FDA Health IT Oversight
News Briefs: Device Tax Repeal Momentum; J&J Settles Hip Suit; Mobile Medical Apps Bill
FDA Role, Safety Oversight Addressed In Health IT Framework Comments
Digital Health In Brief
HHS Health IT Regulations Work Group Sets Path Forward
FDA Reiterates Intention To Regulate Only A Small Portion Of Mobile Medical Apps

Topics

Advertisement
UsernamePublicRestriction

Register

MT032219

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel